Green synthesis of silver and gold nanoparticles using Crataegus oxyacantha extract and their urease inhibitory activities

• Published in: Biotechnology and applied biochemistry Vol. 68; no. 5; p. 992
• Main Authors: Ali, Shujat, Bacha, Misal, Shah, Muhammad Raza, Shah, Wahid, Kubra, Khadijatul, Khan, Ajmal, Ahmad, Manzoor, Latif, Abdul, Ali, Mumtaz
• Format: Journal Article
• Language: English
• Published: United States 01.10.2021
• Subjects: Canavalia - enzymology; Crataegus - chemistry; Enzyme Inhibitors - chemistry; Enzyme Inhibitors - isolation & purification; Enzyme Inhibitors - pharmacology; Gold - chemistry; Gold - pharmacology; Green Chemistry Technology; Metal Nanoparticles - chemistry; Particle Size; Phytochemicals - chemistry; Phytochemicals - isolation & purification; Phytochemicals - pharmacology; Plant Extracts - chemistry; Plant Extracts - isolation & purification; Plant Extracts - pharmacology; Silver - chemistry; Silver - pharmacology; Urease - antagonists & inhibitors; Urease - metabolism; phytochemicals; urease inhibition; green synthesis; Crataegus oxyacantha; Au and Ag nanoparticles
• ISSN: 1470-8744
• DOI: 10.1002/bab.2018

This study reports the green synthesis and urease inhibitory activities of Ag and Au nanoparticles (NPs) using Crataegus oxyacantha extract. The synthesized NPs were characterized by UV-visible, FT-IR spectroscopy, atomic force microscopy, and scanning electron microscopy. The obtained NPs were spherical in shape, and their size was around 85 nm. A strong correlation between the phytochemicals present in the extract and their capability for the synthesis of NPs was observed. Furthermore, the shape, size, stability, and bioactivity of the NPs were strongly influenced by the stabilizing phytochemicals. The experimental analysis suggested that these NPs have substantial stability in a diverse range of physiological conditions such as pH, salinity, and temperature. The NPs exhibited potent urease enzyme inhibitory activities with percent inhibition of 99.25 and IC value of 1.38 ± 0.3, comparable to the standard (thiourea percent inhibition, that is, 98.2% and IC value 5.3 ± 0.04). These results suggested that the proposed NPs could be used in the homeopathic and pharmaceutical industries for biomedical applications.